A new low in pharma/Thanks BMS

Has BMS stooped to a new low?

  • Yes

    Votes: 0 0.0%
  • No

    Votes: 0 0.0%
  • I have my nose so far up Senior Management's butt I don't know.

    Votes: 0 0.0%

  • Total voters
    0

anonymous

Guest
First, you flood oncology offices with a bunch of overpaid, whiny, cry-baby primary care reps that "close for the next 10 patients" on every call. Then you establish stupid "call average" metrics. Again, a primary care tactic that does not work in oncology. Then you stoop to a new low---you start doing direct-to-consumer advertising on a niche oncology lung cancer drug. The problem with this is the commercial gives an impression of false hope. Sure, you may extend life after you scare the crap out of them with all those side effects. But this is about as cheap as attorney's advertising. Why don't you guys sponsor the Jerry Springer show if you are going to do this? Just sick and sad.

Now, you are leaking data that Metformin (the pancreas killer) might be an anti-aging drug in hopes of driving off-label sales. Weren't you guys operating under a FTC/FDA Corporate Intelligence Agreement? Did you not gain any "intelligence" while on that agreement? I hope the FDA comes down hard on this. You are destroying any last ounce of integrity pharma might have. Sad to see you guys ruin it for everyone.

And stop telling accounts that all staff appears on the Sunshine Act report. That is not the case and if you are reporting staff on that, you are going to really have some enemies.
 




Culture here sucks and our leadership is even worse. The entire company is a primary care organization who has talked themselves into thinking they are biotech.

If you call crap a "Picasso" it's not fine art, it is still "poop".
 
























Stability and safety. Your IQ is low at best. Whatever happen to driving results, doing what's right for the patients and actually enjoying making a difference. "passion for success" is not one of the biobehaviors. What a freaken joke this place has turned into.
 








I'm crying. All the way to the bank cause I don't have to be accountable for results, I stay off the radar, try to be fake and act nice to others and get 4-5's on my reviews. When you get done wiping of the cream sauce from your chin, could you please pass me a tissue, my eyes are tearing up again.
 




Stability and safety. Your IQ is low at best. Whatever happen to driving results, doing what's right for the patients and actually enjoying making a difference. "passion for success" is not one of the biobehaviors. What a freaken joke this place has turned into.

Hahahahahaha. You're believing too much bullshit. Patients are the last priority in this greedy business. Profit is the only reason we exist. Medicine is a business, not a humanitarian endeavor. Wake up you naive
 




what, patients aren't at the center of everything we do? what about being all in for all patients?

does this mean we are only interested in every dollar a patient has? that seems to be what you are saying.

pretty bad if that's the true message. a new low for sure.
 




what, patients aren't at the center of everything we do? what about being all in for all patients?

does this mean we are only interested in every dollar a patient has? that seems to be what you are saying.

pretty bad if that's the true message. a new low for sure.

Pretty close. Cancer drugs a prime example. Not many breakthroughs in many years.
Prices stay high so no major reason to come out with any new ones. Merck was a leader in hypocrisy with Vioxx. They knew it was poison before it ever hit the market, but their "patients first profits second "bullshit continued to be spoute up until the day it was pulled. They used simple math. Profits would far exceed lawsuits.
Drugs save and improve the quality of millions but they wouldn't be available if there wasn't a high profit margin. Marketing budgets exceed R&D budgets across the board. This industry/company has employed many people, made great careers for many, but don't believe profits don't trump
Patients every time, another prime e ample comes to mind. Orphan drugs....huge benefit to a small number of patients, low profits. That's why you don't see many, and when you do the price is astronomical. The new HepC one comes to mind.
 




many senior leaders here are from primary care, old mind set, average IQ, dead wood.

And you're a genius? Yeah, sure. Oncology no different tha PC. Actually less...Onc's know more about the drug than you do...and much sooner. Get off your elitist high horse. Drug sales are drug sales. A lunch is a lunch, a paid company shill is the same.
 




First, you flood oncology offices with a bunch of overpaid, whiny, cry-baby primary care reps that "close for the next 10 patients" on every call. Then you establish stupid "call average" metrics. Again, a primary care tactic that does not work in oncology. Then you stoop to a new low---you start doing direct-to-consumer advertising on a niche oncology lung cancer drug. The problem with this is the commercial gives an impression of false hope. Sure, you may extend life after you scare the crap out of them with all those side effects. But this is about as cheap as attorney's advertising. Why don't you guys sponsor the Jerry Springer show if you are going to do this? Just sick and sad.

Now, you are leaking data that Metformin (the pancreas killer) might be an anti-aging drug in hopes of driving off-label sales. Weren't you guys operating under a FTC/FDA Corporate Intelligence Agreement? Did you not gain any "intelligence" while on that agreement? I hope the FDA comes down hard on this. You are destroying any last ounce of integrity pharma might have. Sad to see you guys ruin it for everyone.

And stop telling accounts that all staff appears on the Sunshine Act report. That is not the case and if you are reporting staff on that, you are going to really have some enemies.
money money money !!
 




Pretty close. Cancer drugs a prime example. Not many breakthroughs in many years.
Prices stay high so no major reason to come out with any new ones. Merck was a leader in hypocrisy with Vioxx. They knew it was poison before it ever hit the market, but their "patients first profits second "bullshit continued to be spoute up until the day it was pulled. They used simple math. Profits would far exceed lawsuits.
Drugs save and improve the quality of millions but they wouldn't be available if there wasn't a high profit margin. Marketing budgets exceed R&D budgets across the board. This industry/company has employed many people, made great careers for many, but don't believe profits don't trump
Patients every time, another prime e ample comes to mind. Orphan drugs....huge benefit to a small number of patients, low profits. That's why you don't see many, and when you do the price is astronomical. The new HepC one comes to mind.

That is sad. I feel bad for the people that got sick or died from these poisons being pushed as cures.